These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22348215)

  • 1. [Venous access devices in oncology].
    Maňásek V; Soumarová R; Kociánová I; Maňásková M
    Klin Onkol; 2012; 25(1):9-16. PubMed ID: 22348215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours.
    Cheong K; Perry D; Karapetis C; Koczwara B
    Intern Med J; 2004 May; 34(5):234-8. PubMed ID: 15151668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central venous catheters for infusion therapy in gastrointestinal cancer. A comparative study of tunnelled centrally placed catheters and peripherally inserted central catheters.
    Snelling R; Jones G; Figueredo A; Major P
    J Intraven Nurs; 2001; 24(1):38-47. PubMed ID: 11836843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing concepts in long-term central venous access: catheter selection and cost savings.
    Horattas MC; Trupiano J; Hopkins S; Pasini D; Martino C; Murty A
    Am J Infect Control; 2001 Feb; 29(1):32-40. PubMed ID: 11172316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters.
    Cowl CT; Weinstock JV; Al-Jurf A; Ephgrave K; Murray JA; Dillon K
    Clin Nutr; 2000 Aug; 19(4):237-43. PubMed ID: 10952794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of peripherally inserted central catheters in the management of recalcitrant maxillofacial infection.
    Islam S; Loewenthal MR; Hoffman GR
    J Oral Maxillofac Surg; 2008 Feb; 66(2):330-5. PubMed ID: 18201618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular access in neonates and infants--indications, routes, techniques and devices, complications.
    Möller JC; Reiss I; Schaible T
    Intensive Care World; 1995 Jun; 12(2):48-53. PubMed ID: 10150755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central venous access devices in treatment of patients with malignant tumors: venous port, central venous catheter and Hickman catheter. Cost-benefit analysis based on a critical review of the literature, personal experiences with 135 port implantations and patient attitude].
    Krupski G; Fröschle GW; Weh FJ; Schlosser GA
    Chirurg; 1995 Mar; 66(3):202-7. PubMed ID: 7750390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Permanent venous access through a +portacath reservoir in patients receiving prolonged chemotherapy].
    García H; Díaz R; Pablo Barés J; Nevah E; Fábrega JM
    Rev Med Panama; 1994 Jan; 19(1):8-12. PubMed ID: 7938718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fully implantable catheter systems. Long-term results--complications].
    Wenke K; Markewitz A
    Fortschr Med; 1990 May; 108(14):276-9. PubMed ID: 2115492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the complications of long-term venous access.
    Hoch JR
    Semin Vasc Surg; 1997 Sep; 10(3):135-43. PubMed ID: 9304729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral ports are a new option for central venous access.
    Schuman E; Ragsdale J
    J Am Coll Surg; 1995 Apr; 180(4):456-60. PubMed ID: 7719550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventional radiology in the provision and maintenance of long-term central venous access.
    Lyon SM; Given M; Marshall NL
    J Med Imaging Radiat Oncol; 2008 Feb; 52(1):10-7. PubMed ID: 18373820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Moss JG; Wu O; Bodenham AR; Agarwal R; Menne TF; Jones BL; Heggie R; Hill S; Dixon-Hughes J; Soulis E; Germeni E; Dillon S; McCartney E;
    Lancet; 2021 Jul; 398(10298):403-415. PubMed ID: 34297997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripherally inserted central catheters and their use in i.v. therapy.
    Todd J
    Br J Nurs; 1999 Feb 11-24; 8(3):140-2, 144, 146-8. PubMed ID: 10222875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.